Cardiovascular Aging

Cardiovascular Aging

Aging is a slow, progressive, and inevitable process that affects multiple organs and tissues, including the cardiovascular system. The most frequent cardiac and vascular alterations that are observed in older adults (especially patients aged ≥80 years) are diastolic and systolic dysfunction, progre...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marco Tana, Rachele Piccinini, Livia Moffa, Ettore Porreca, Fernando Tana, Claudio Tana
Format:	Article
Language:	English
Published:	IMR Press 2025-07-01
Series:	Reviews in Cardiovascular Medicine
Subjects:	cardiovascular aging cardiac amyloidosis heart failure ejection fraction oxidative stress
Online Access:	https://www.imrpress.com/journal/RCM/26/7/10.31083/RCM27437
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis
by: Mileydis Alonso, et al.
Published: (2024-12-01)

First report of the clinical characteristics and outcomes of cardiac amyloidosis in Saudi Arabia
by: Omar Ahmad, et al.
Published: (2024-12-01)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021-03-01)

Left Ventricular Ejection Fraction in Heart Failure: Crazy, Stupid Love—and Maybe, Redemption
by: Milton Packer
Published: (2024-04-01)

Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction
by: Z. M. Akhilgova, et al.
Published: (2021-06-01)

Dynamics of heart failure markers and cardiac reverse remodeling in patients receiving cardiac contractility modulation therapy
by: M. A. Vander, et al.
Published: (2021-02-01)

Is there the phenotype of chronic heart failure with “intermediate” left ventricular ejection fraction? Additional echocardiographic criteria for left ventricular systolic dysfunction in patients with chronic heart failure of ischemic origin with ejection fraction in the “gray area”
by: V. V. Syvolap, et al.
Published: (2021-06-01)

Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction
by: Song‐Yun Chu, et al.
Published: (2025-02-01)

Temporal left ventricular ejection fraction variations and outcomes in wide population of cardiovascular patients with and without heart failure
by: Radosław Szczerba, et al.
Published: (2025-03-01)

Systemic Amyloidosis with Cardiac Involvement: Features of Course and Diagnostic Difficulties
by: E. V. Voloshinova, et al.
Published: (2024-08-01)

Atypical Presentation of Multiple Myeloma: From Heart Failure to Multiple Myeloma
by: Ainur Elliana Sohaimi, et al.
Published: (2024-10-01)

Editorial: Cardiac reverse remodeling after novel heart failure therapies—volume II
by: Christian Basile, et al.
Published: (2025-01-01)

Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry
by: Laura Landucci, et al.
Published: (2025-03-01)

Clinical management of heart failure with improved ejection fraction: treatment and maintenance
by: XU Tianyun, et al.
Published: (2025-04-01)

Retrospective analysis of cardiovascular involvement in patients with systemic amyloidosis
by: E. V. Reznik, et al.
Published: (2021-02-01)

Comparison of the effects of metformin and empagliflozin on cardiac function in heart failure with preserved ejection fraction mice
by: Xiehong Liu, et al.
Published: (2025-04-01)

AMYLOIDOSIS HEART IN ELDERLY
by: L. I. Dvoretsky, et al.
Published: (2015-12-01)

Effect of Noncardiac Comorbidities on Quality of Life among Patients with Heart Failure - An Observational Study
by: J. Anusha, et al.
Published: (2025-07-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Gender‐specific risks for incident cancer in patients with different heart failure phenotypes
by: Qin‐Fen Chen, et al.
Published: (2025-02-01)

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

Impact of Obstructive Sleep Apnea in Patients with Acute Heart Failure: A Nationwide Cohort Study
by: Abdulmajeed Alharbi, et al.
Published: (2024-11-01)

About the classification of heart failure
by: A. S. Galyavich, et al.
Published: (2023-09-01)

Features of chronic heart failure depending on the left ventricular ejection fraction
by: A. G. Dushina, et al.
Published: (2019-03-01)

Results of the Russian Society of Cardiology survey "Chronic heart failure. Unsolved issues"
by: O. B. Irtyuga, et al.
Published: (2024-06-01)

The role of free nucleotides in heart failure
by: E. V. Kolesnikova, et al.
Published: (2025-03-01)

Characteristics, outcomes and the necessity of continued guideline-directed medical therapy in patients with heart failure with improved ejection fraction
by: Qin-Fen Chen, et al.
Published: (2025-12-01)

Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction
by: E. F. Muslimova, et al.
Published: (2025-01-01)

Lipoprotein(a) and Heart Failure Among Black and White Participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and Multi‐Ethnic Study of Atherosclerosis: The Pooling Project
by: Sarah Nomura, et al.
Published: (2025-06-01)

Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score
by: Flavia-Mihaela Stoiculescu, et al.
Published: (2025-07-01)

The Impact of Continuous Cardiac Rehabilitation on the Psychological and Physiological Prognosis of Patients with Heart Failure&mdash;A Retrospective Study
by: Yan LH, et al.
Published: (2025-08-01)

Importance of non‐cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction
by: Yasuhiro Hamatani, et al.
Published: (2025-02-01)

The Value of Biomarkers in the Diagnosis and Prognosis of Heart Failure in Older Age
by: V. N. Larina, et al.
Published: (2021-03-01)

Mitochondrial Reactive Oxygen Species Dysregulation in Heart Failure with Preserved Ejection Fraction: A Fraction of the Whole
by: Caroline Silveira Martinez, et al.
Published: (2024-10-01)

The correlation between lipoprotein(a) and major adverse cardiovascular events in patients with acute myocardial infarction combined with heart failure with preserved ejection fraction
by: Xiaodong Zhang, et al.
Published: (2025-06-01)

V<sub>o2peak</sub>, Ve/V<sub>CO2</sub>, and Cardiac Remodeling Correlate with Long-Term Cardiovascular Outcome in Heart Failure Patients
by: Antonio Pagliaro, et al.
Published: (2025-05-01)

Left atrioventricular coupling index measured by echocardiography in heart failure with preserved ejection fraction
by: Hai Nguyen Ngoc Dang, et al.
Published: (2025-07-01)

Circulating Cell-Free Nuclear DNA Predicted an Improvement of Systolic Left Ventricular Function in Individuals with Chronic Heart Failure with Reduced Ejection Fraction
by: Tetiana Berezina, et al.
Published: (2024-10-01)

Running on empty: Factors underpinning impaired cardiac output reserve in heart failure with preserved ejection fraction
by: Paula Sagmeister, et al.
Published: (2025-05-01)

Effect of therapy on the dynamics of collagen metabolism markers in older patients with heart failure with mid-range ejection fraction and coronary artery disease
by: O. A. Osipova, et al.
Published: (2020-11-01)